Targeted Oncology

Treating Together

Health EN ↓ 89 episodes

Targeted Oncology brings you Treating Together , a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.

Author

Targeted Oncology

Episodes

S4 Ep13: Strategies for Neoadjuvant NSCLC Treatment 01.09.2023 10:04

An interview with Benny Weskler, MBA, MD, FACS, FACCP of Allegheny Health Network.

S4 Ep12: Lessons from Real-World Cases of Small Cell Lung Cancer 15.08.2023 16:53

Federico Albrecht, MD discusses 2 small cell lung cancer cases.

S4 Ep11: Social Determinants of Health Impacting Oncology Today 31.07.2023 10:16

S4 Ep10: Recommendations for Treating Central Nervous Systems Cancers 14.07.2023 8:19

Craig Horbinski, MD, PhD, unpacks the NCCN Clinical Practice Guidelines for central nervous system tumors.

S4 Ep9: Mitigating Cardiotoxicity Resulting from Immune Checkpoint Inhibitor Therapy 30.06.2023 12:43

In season 4, episode 9 of Targeted Talks, Kerry Reynolds, MD of Massachusetts General Hospital discusses the occurrence of myocarditis in patients with cancer treated with immune checkpoint inhibitors.

S4 Ep8: Pushing Forward With Molecularly-Driven Precision Medicine in Endometrial Cancer 23.06.2023 21:12

An interview with Ruchi Garg, MD of City of Hope.

S4 Ep7: Exciting Activity in Chronic Lymphocytic Leukemia 31.05.2023 8:05

S4 Ep6: Anticipating Novel Treatments for the RAI-Refractory DTC Armamentarium 15.05.2023 8:32

An interview with Warren Swegal, MD.

S4 Ep5: Advancing the Treatment of Alveolar Soft Part Sarcoma 26.04.2023 13:16

An interview with Alice P. Chen, MD of the National Cancer Institute.

S4 Ep4: Understanding and Treating Mucosal Melanoma 14.04.2023 11:44

Richard D. Carvajal, MD, discusses mucosal melanoma and treatment options for the disease.

S4 Ep3: Hitting New Targets in Metastatic Prostate Cancer 16.03.2023 12:31

In season 4, episode 3 of Targeted Talks, Pedro Barata, MD, MSc, discusses the present and future of prostate cancer precision medicine.

S4 Ep2: The Importance of Trastuzumab Deruxtecan in HER2+ Breast Cancer Treatment 28.02.2023 9:48

A talk with Sara A. Hurvitz, MD about advances in the HER2-positive breast cancer space.

S4 Ep1: Unpacking the Latest Research in Gastrointestinal Cancers 15.02.2023 17:36

In season 4, episode 1 of Targeted Talks, Benjamin L. Schlechter, MD, of Dana-Farber Cancer Institute discuses new studies in gastrointestinal malignancies.

S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment 17.11.2022 21:04

In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America Atlanta, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.

S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment 17.11.2022 21:04

In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.

S3 Ep9: Special Episode: Managing Cardiotoxicity from ICI Therapy in Patients with Cancer 25.10.2022 17:45

In season 3, episode 9 of Targeted Talks, Mohammed Salhab, MD, Chris Fine, MD, FACC, cardiologist at National Jewish Health, have a special discussion about cardiotoxicity from immune checkpoint inhibitor therapy in patients with cancer.

S3 Ep8: Treating HER2-Positive Beast Cancer in the Community Setting 16.09.2022 17:24

In season 3, episode 8 of Targeted Talks, Christie J. Hilton, DO, discusses treating first- and second-line HER2-positive breast cancer.

S3 Ep7: The Evolution of Endometrial Cancer Treatment 15.08.2022 9:36

In season 3, episode 7 of Targeted Talks, John Nakayama, MD, a gynecologic oncologist at Allegheny Health Network, discusses updates in the endometrial cancer treatment landscape.

S3 Ep6: Examining the Non-Hodgkin Lymphoma Treatment Paradigm 15.07.2022 12:36

Yazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.

S3 Ep5: The Road to Improving Diffuse Large B-Cell Lymphoma Treatment 15.06.2022 8:47

In season 3, episode 5 of Targeted Talks, Thomas Habermann, MD, discusses the latest advances in the treatment of diffuse large B-cell lymphoma.

S3 Ep4: Better Strategies for the Treatment of High-Risk Chronic Lymphocytic Leukemia 17.05.2022 10:37

In season 3, episode 4 of Targeted Talks, Alexey Danilov, MD, PhD, discusses the shift toward utilizing cellular therapy to treat high-risk patients with chronic lymphocytic leukemia.

S3 Ep3: Unpacking the New Recommendations for Early-Stage Breast Cancer Management 15.04.2022 13:16

In season 3, episode 3 of Targeted Talks, William J. Gradishar, MD, discusses the latest version of the NCCN Clinical Practice Guidelines for managing early-stage breast cancer.

S3 Ep2: Advances and Pending Innovations in the Treatment of Sarcoma 16.03.2022 18:39

Mark Agulnik, MD, City of Hope Comprehensive Cancer Center joins Targeted Oncology for a discussion about the sarcoma treatment landscape and pending innovations under investigation in clinical trials.

S3 Ep1: A Look Inside the Toolbox for BRAF-Mutant Metastatic Melanoma 15.02.2022 9:24

In season 3, episode 1 of Targeted Talks, Michael A. Postow, MD, discusses available targeted agents for BRAF-mutant melanoma and ongoing clinical questions about treating the disease.

S2 Ep10: Treating Sarcoma With a Multidisciplinary Approach 15.12.2021 16:37

Sandra P. D'Angelo, MD and Katherine Poruk, MD